Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies

Posted on 19 May 2025 by perspectum

Leave a Reply

Your email address will not be published. Required fields are marked *